Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Mol Med. 2013 Feb;31(2):353-60. doi: 10.3892/ijmm.2012.1206. Epub 2012 Dec 6.

Novel rotundic acid derivatives: synthesis, structural characterization and in vitro antitumor activity.

Author information

  • 1Department of Pathogenobiology, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, P.R. China.

Abstract

Six novel rotundic acid (RA, 1) derivatives 4a-4f modified at the 28-COOH position were synthesized, and their structures were confirmed by IR, MS, 1H NMR and 13C NMR. The derivatives were evaluated for cytotoxic properties on the following three tumor cell lines: HeLa, HepG2 and SGC-7901. Compound 4f showed better cytotoxic activity compared with RA treatment and lower IC50 (4.16 µM) on HepG2 cells than on HeLa (8.54 µM) and SGC-7901 cells (11.32 µM). The anticancer mechanism of compound 4f was studied through cell cycle progression and apoptosis. Notably, compound 4f was able to induce apoptosis and G0/G1 cell cycle arrest of HepG2 at a concentration of 4.16 µM. In summary, RA was modified to obtain six novel derivatives. Compound 4f exhibited better cytotoxicity and may be developed as a potential agent against hepatocellular carcinoma.

PMID:
23233042
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Spandidos Publications
    Loading ...
    Write to the Help Desk